These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8938567)

  • 1. Role of interferon-stimulated gene ISG-15 in the interferon-omega-mediated inhibition of human immunodeficiency virus replication.
    Künzi MS; Pitha PM
    J Interferon Cytokine Res; 1996 Nov; 16(11):919-27. PubMed ID: 8938567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
    Hagelstein J; Kist A; Stremmel W; Galle PR
    Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.
    Buckwold VE; Wei J; Huang Z; Huang C; Nalca A; Wells J; Russell J; Collins B; Ptak R; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
    Antiviral Res; 2007 Feb; 73(2):118-25. PubMed ID: 16987555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restriction of HIV replication in infected T cells and monocytes by interferon-alpha.
    Gendelman HE; Baca L; Turpin JA; Kalter DC; Hansen BD; Orenstein JM; Friedman RM; Meltzer MS
    AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1045-9. PubMed ID: 2121192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.
    Korth MJ; Taylor MD; Katze MG
    Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle.
    Shirazi Y; Pitha PM
    J Virol; 1992 Mar; 66(3):1321-8. PubMed ID: 1738192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
    Popik W; Pitha PM
    Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cytokine and viral gene expression in monocytes infected with the human immunodeficiency virus.
    Meltzer MS; Baca L; Turpin JA; Kalter DC; Dieffenbach C; Friedman RM; Gendelman HE
    Pathobiology; 1991; 59(4):209-13. PubMed ID: 1883515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
    Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
    Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo.
    Pan Q; de Ruiter PE; Metselaar HJ; Kwekkeboom J; de Jonge J; Tilanus HW; Janssen HL; van der Laan LJ
    Hepatology; 2012 Jun; 55(6):1673-83. PubMed ID: 22213147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of alfa interferon and ampligen of human immunodeficiency virus (HIV) replication in monocyte-macrophage subpopulations].
    Bergamini A; Ercoli L; Perno CF
    Medicina (Firenze); 1990; 10(1):34-6. PubMed ID: 2381279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HIV potential of a new interferon, interferon-tau (trophoblastin).
    Dereuddre-Bosquet N; Clayette P; Martin M; Mabondzo A; Frétier P; Gras G; Martal J; Dormont D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Mar; 11(3):241-6. PubMed ID: 8603260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of HIV replication in infected monocytes by IFN-alpha. Mechanisms for viral restriction.
    Gendelman HE; Baca LM; Turpin J; Kalter DC; Hansen B; Orenstein JM; Dieffenbach CW; Friedman RM; Meltzer MS
    J Immunol; 1990 Oct; 145(8):2669-76. PubMed ID: 1976701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cART Restores Transient Responsiveness to IFN Type 1 in HIV-Infected Humanized Mice.
    Gruenbach M; Muller CKS; Schlaepfer E; Baroncini L; Russenberger D; Kadzioch NP; Escher B; Schlapschy M; Skerra A; Bredl S; Speck RF
    J Virol; 2022 Nov; 96(21):e0082722. PubMed ID: 36250708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety pharmacology, toxicology and pharmacokinetic assessment of recombinant human omega-interferon produced from CHO-SS cells.
    Buckwold VE; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):62-70. PubMed ID: 16867173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro.
    Montefiori DC; Mitchell WM
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2985-9. PubMed ID: 3106982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor-alpha, interferon-gamma and interferon-beta exert antiviral activity in nervous tissue cells.
    Schijns VE; Van der Neut R; Haagmans BL; Bar DR; Schellekens H; Horzinek MC
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():809-15. PubMed ID: 1849968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells.
    Shirazi Y; Pitha PM
    Virology; 1993 Mar; 193(1):303-12. PubMed ID: 8438572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins.
    Agy MB; Acker RL; Sherbert CH; Katze MG
    Virology; 1995 Dec; 214(2):379-86. PubMed ID: 8553538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.